Sprayable barrier and methods for prevention of postoperative adhesions
Biologically acceptable surgical barrier materials are comprised of a polyelectrolytic complex of chitosan and sodium alginate. The chitosan is deacetylated in an amount between about 40 to about 60% and has a molecular weight (Mw) between 50,000 and 375,000 g/mol. The barrier materials may be formed by mixing a two-component material system whereby one component comprises the chitosan and a second component comprises the sodium alginate and directing such a mixture (e.g., via air-assisted spray nozzle) toward a surgical site in need of the material. A polyelectrolytic complex of the chitosan and sodium alginate will thereby form in situ. Suitable ionic cross-linkers may be provided in the individual components, e.g., calcium chloride with the chitosan component and sodium tripolyphosphate with the sodium alginate component.
1. A method of forming a biologically acceptable barrier material at a surgical site comprising:
(i) providing a barrier material system comprised of separate first and second solutions, wherein:
(a) the first solution comprises:
(a1) a water soluble chitosan which is deacetylated in an amount between about 40% to about 60%, and
(a2) calcium chloride as a first ionic cross-linker, and
(b) the second solution comprises:
(b1) sodium alginate, and
(b2) sodium tripolyphosphate (NaTPP) as a second ionic cross-linker,
(ii) mixing the first and second solutions of the barrier material system in a mixing chamber to form a sprayable polyelectrolytic hydrogel complex of the chitosan and sodium alginate,
(iii) immediately after the mixing according to step (ii), expelling the sprayable polyelectrolytic hydrogel complex from the mixing chamber and directing the sprayable polyelectrolytic hydrogel complex expelled from the mixing chamber toward the surgical site, and
(iv) allowing a surgical barrier material formed of the polyelectrolytic hydrogel complex of the chitosan and sodium alginate to form in situ at the surgical site by allowing the sodium alginate in the second solution to be cross-linked by the first ionic cross-linker in the first solution and the chitosan in the first solution to be cross-linked by the second ionic cross-linker in the second solution.
2. The method according to claim 1 , wherein steps (ii) and (iii) are practiced using a manual or a gas-assisted mixing and spray applicator.
3. The method according to claim 1 , wherein steps (ii) and (iii) are practiced with a gas-assisted mixing and spray applicator using atmospheric air or carbon dioxide gas at an atomizing pressure of between about 5 psi to about 15 psi.
4. The method according to claim 1 , wherein at least one of the first and second solutions comprises a biologically acceptable colorant.
5. The method according to claim 4 , wherein the second solution comprises the colorant, and wherein the colorant is present in the second solution in an amount of 0.005 wt. % to 1.0 wt. %, based on total weight of the second solution.
6. The method according to claim 1 , wherein the first solution comprises 1 to 2 wt. %, based on the total weight of the first solution, of calcium chloride as the first ionic crosslinker.
7. The method according to claim 6 , wherein the second solution comprises between about 0.5 to about 1.5 wt. %, based on the total weight of the second solution, of the sodium tripolyphosphate as the second ionic crosslinker.
8. The method according to claim 1 , wherein step (iv) comprises forming the surgical barrier of the polyelectrolytic hydrogel complex of the chitosan and sodium alginate in less than about 1 minute.
9. The method according to claim 1 , wherein step (i) comprises providing the first and second solutions in respective syringes.
10. The method according to claim 1 , wherein step (ii) comprises concurrently passing the first and second solutions through a mixing tip to thereby mix the first and second solutions within the mixing tip to thereby form the sprayable polyelectrolytic hydrogel complex of the chitosan and sodium alginate.
11. The method according to claim 10 , wherein step (iii) comprises expelling the sprayable polyelectrolytic hydrogel complex of the chitosan and sodium alginate from the mixing tip toward the surgical site.
12. The method according to claim 1 , wherein the chitosan has a molecular weight (Mw) between 50,000 and 375,000 g/mol.
13. The method according to claim 12 , wherein the first solution comprises 1 to 2 wt. %, based on the total weight of the first solution, of calcium chloride as the first ionic crosslinker.
14. The method according to claim 13 , wherein the second solution comprises between about 0.5 to about 1.5 wt. %, based on the total weight of the second solution, of the sodium tripolyphosphate as the second ionic crosslinker.
15. The method according to claim 14 , wherein the second solution comprises 0.25 to about 0.5% w/v of the sodium alginate, and wherein the sodium alginate has a molecular weight of from about 75,000 to about 500,000 g/mol.
16. The method according to claim 15 , wherein at least one of the first and second solutions comprises a biologically acceptable colorant.
17. The method according to claim 16 , wherein the second solution comprises the colorant, and wherein the colorant is present in the second solution in an amount of 0.005 wt. % to 1.0 wt. %, based on total weight of the second solution.